Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in Puma Biotechnology, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 118
- No complete 13F data for Q4 2020
- Shares held
- 36.6M
- No complete 13F data for Q4 2020
- Total value
- $355.9M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting PBYI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 160 | $313.6M |
| Q1 2026 | 157 | $241.8M |
| Q4 2025 | 151 | $210.2M |
| Q3 2025 | 132 | $182.5M |
| Q2 2025 | 121 | $112.5M |
| Q1 2025 | 116 | $90.0M |
| Q4 2024 | 112 | $89.7M |
| Q3 2024 | 100 | $75.9M |
| Q2 2024 | 99 | $100.9M |
| Q1 2024 | 93 | $157.7M |
| Q4 2023 | 82 | $115.2M |
| Q3 2023 | 69 | $67.6M |
| Q2 2023 | 68 | $93.8M |
| Q1 2023 | 78 | $86.1M |
| Q4 2022 | 89 | $116.3M |
| Q3 2022 | 83 | $65.5M |
| Q2 2022 | 89 | $79.5M |
| Q1 2022 | 104 | $86.1M |
| Q4 2021 | 102 | $92.2M |
| Q3 2021 | 116 | $226.0M |
| Q2 2021 | 120 | $319.3M |
| Q1 2021 | 118 | $355.9M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Puma Biotechnology, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,904 | $48.0K | 0.00% | – | – |
| FORA Capital, LLC | 3,470 | $34.0K | 0.01% | – | – |
| Pacer Advisors, Inc. | 2,837 | $28.0K | 0.00% | – | – |
| Lindbrook Capital, LLC | 2,793 | $27.0K | 0.01% | – | – |
| Storebrand Asset Management AS | 2,650 | $25.8K | 0.00% | – | – |
| Ameritas Investment Partners, Inc. | 2,522 | $25.0K | 0.00% | – | – |
| MetLife Investment Management | 2,392 | $23.3K | 0.00% | – | – |
| Great West Life Assurance Co | 2,002 | $19.0K | 0.00% | – | – |
| Captrust Financial Advisors | 1,500 | $15.0K | 0.00% | – | – |
| Group One Trading, L.P. | 1,100 | $11.0K | 0.00% | – | – |
| Geneos Wealth Management Inc. | 1,000 | $9.00K | 0.00% | – | – |
| Penserra Capital Management LLC | 905 | $8.00K | 0.00% | – | – |
| IFP Advisors, Inc | 923 | $8.00K | 0.00% | – | – |
| US Bancorp | 510 | $5.00K | 0.00% | – | – |
| Baillie Gifford & Co | 252 | $2.00K | 0.00% | – | – |
| Trust Co of Vermont | 100 | $1.00K | 0.00% | – | – |
| Daiwa Securities Group Inc. | 87 | $1.00K | 0.00% | – | – |
| Cutler Group LP | 200 | $1.00K | 0.00% | – | – |